Immunological Barriers to Stem Cell Therapy in the Central Nervous System

Joint Authors

Kirk, Mark D.
Tullis, Gregory E.
Spears, Kathleen

Source

Stem Cells International

Issue

Vol. 2014, Issue 2014 (31 Dec. 2014), pp.1-12, 12 p.

Publisher

Hindawi Publishing Corporation

Publication Date

2014-08-05

Country of Publication

Egypt

No. of Pages

12

Abstract EN

The central nervous system is vulnerable to many neurodegenerative disorders such as Alzheimer’s disease that result in the extensive loss of neuronal cells.

Stem cells have the ability to differentiate into many types of cells, which make them ideal for treating such disorders.

Although stem cell therapy has shown some promising results in animal models for many brain disorders it has yet to translate into the clinic.

A major hurdle to the translation of stem cell therapy into the clinic is the immune response faced by stem cell transplants.

Here, we focus on immunological and related hurdles to stem cell therapies for central nervous system disorders.

American Psychological Association (APA)

Tullis, Gregory E.& Spears, Kathleen& Kirk, Mark D.. 2014. Immunological Barriers to Stem Cell Therapy in the Central Nervous System. Stem Cells International،Vol. 2014, no. 2014, pp.1-12.
https://search.emarefa.net/detail/BIM-1047523

Modern Language Association (MLA)

Tullis, Gregory E.…[et al.]. Immunological Barriers to Stem Cell Therapy in the Central Nervous System. Stem Cells International No. 2014 (2014), pp.1-12.
https://search.emarefa.net/detail/BIM-1047523

American Medical Association (AMA)

Tullis, Gregory E.& Spears, Kathleen& Kirk, Mark D.. Immunological Barriers to Stem Cell Therapy in the Central Nervous System. Stem Cells International. 2014. Vol. 2014, no. 2014, pp.1-12.
https://search.emarefa.net/detail/BIM-1047523

Data Type

Journal Articles

Language

English

Notes

Includes bibliographical references

Record ID

BIM-1047523